Genetic Technologies (GENE) Sees Uptick in BREVAGen Sales from Improvement in PPO Reimbursement
Go back to Genetic Technologies (GENE) Sees Uptick in BREVAGen Sales from Improvement in PPO Reimbursement| Genetic Technologies Ltd. (NASDAQ: GENE) | Delayed: 0.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.77 | 52 Week High | $4.27 | |||
| Open | $0.77 | 52 Week Low | $1.20 | |||
| Day High | $0.77 | P/E | N/A | |||
| Day Low | $0.77 | EPS | $0.00 | |||
| Volume | 144,543 | |||||
